Recent Developments of Target-Based Benzimidazole Derivatives as Potential Anticancer Agents
Cancer is one of the major life burdens and around 18.1 million new cancer cases and 9.6 million deaths have been estimated in 2018 globally. Recent reports of the World Health Organization (WHO) stated that about one in six death cases globally is mainly due to cancer. Hence, the development of eff...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/70696 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Recent Developments of Target-Based Benzimidazole Derivatives as Potential Anticancer Agents
- Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside
- Corrosion Mitigation by Planar Benzimidazole Derivatives
- Benzimidazole: Pharmacological Profile
- Spectral and Theoretical Studies of Benzimidazole and 2-Phenyl Substituted Benzimidazoles
- Pharmaceutically Privileged Bioactive Pyridine Derivatives as Anticancer Agents: Synthetic Developments and Biological Applications
- Surface-Confined Ruthenium Complexes Bearing Benzimidazole Derivatives: Toward Functional Devices